Grant RM - Search Results

1

Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.

Roland ME, Martin JN, Grant RM, Hellmann NS, Bamberger JD, Katz MH, Chesney M, Franses K, Coates TJ, Kahn JO. Roland ME, et al. Among authors: grant rm. J Infect Dis. 2001 Dec 15;184(12):1608-12. doi: 10.1086/324580. Epub 2001 Dec 3. J Infect Dis. 2001. PMID: 11740738

2

Infectivity of the human immunodeficiency virus: estimates from a prospective study of homosexual men.

Grant RM, Wiley JA, Winkelstein W. Grant RM, et al. J Infect Dis. 1987 Jul;156(1):189-93. doi: 10.1093/infdis/156.1.189. J Infect Dis. 1987. PMID: 3474298 No abstract available.

3

Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma.

Chuck S, Grant RM, Katongole-Mbidde E, Conant M, Ganem D. Chuck S, et al. Among authors: grant rm. J Infect Dis. 1996 Jan;173(1):248-51. doi: 10.1093/infdis/173.1.248. J Infect Dis. 1996. PMID: 8537669

4

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H, Hellmann NS, Bandrapalli NI, Digilio L, Branson B, Kahn JO. Hecht FM, et al. Among authors: grant rm. N Engl J Med. 1998 Jul 30;339(5):307-11. doi: 10.1056/NEJM199807303390504. N Engl J Med. 1998. PMID: 9682043 Free article. No abstract available.

5

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.

Deeks SG, Hellmann NS, Grant RM, Parkin NT, Petropoulos CJ, Becker M, Symonds W, Chesney M, Volberding PA. Deeks SG, et al. Among authors: grant rm. J Infect Dis. 1999 Jun;179(6):1375-81. doi: 10.1086/314775. J Infect Dis. 1999. PMID: 10228057 Clinical Trial.

6

Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination.

Locher CP, Grant RM, Collisson EA, Reyes-Terán G, Elbeik T, Kahn JO, Levy JA. Locher CP, et al. Among authors: grant rm. AIDS Res Hum Retroviruses. 1999 Dec 10;15(18):1685-9. doi: 10.1089/088922299309720. AIDS Res Hum Retroviruses. 1999. PMID: 10606091

7

Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women.

Greenblatt RM, Ameli N, Grant RM, Bacchetti P, Taylor RN. Greenblatt RM, et al. Among authors: grant rm. J Infect Dis. 2000 Jan;181(1):82-90. doi: 10.1086/315207. J Infect Dis. 2000. PMID: 10608754

8

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

Blower SM, Gershengorn HB, Grant RM. Blower SM, et al. Among authors: grant rm. Science. 2000 Jan 28;287(5453):650-4. doi: 10.1126/science.287.5453.650. Science. 2000. PMID: 10649998

9

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.

Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM. Deeks SG, et al. Among authors: grant rm. J Infect Dis. 2000 Mar;181(3):946-53. doi: 10.1086/315334. J Infect Dis. 2000. PMID: 10720517

10

Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy.

Huang SS, Barbour JD, Deeks SG, Huang JS, Grant RM, Ng VL, McCune JM. Huang SS, et al. Among authors: grant rm. Clin Infect Dis. 2000 Mar;30(3):504-10. doi: 10.1086/313714. Clin Infect Dis. 2000. PMID: 10722435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters